| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.028 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.021 | 0.9 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.017 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0047 | 1 |